BBIO

BridgeBio Pharma Inc (BBIO)

US
$ 33.870.06%

Price Chart

Key Statistics

Market Cap
$ 9.06B
P/E Ratio
0.00
Revenue (TTM)
$ 127.42M
Volume
1.47M
52W High
$ 48.68
52W Low
$ 21.72
Dividend Yield
0.00%
Beta
1.10

Technicals

50-Day MA
38.8409
200-Day MA
32.2953
52 Week High
48.6809
52 Week Low
21.72

About BBIO

BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.

Employees
725
Headquarters
Palo Alto, CA
CEO
Dr. Neil Kumar Ph.D.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
JELD
JELD-WEN Holding In...
$ 4.40
12.24
LVS
Las Vegas Sands Cor...
$ 47.36
8.87
CCS
Century Communities...
$ 61.22
8.70
KTB
Kontoor Brands Inc....
$ 71.65
8.61
BBWI
Bath & Body Works I...
$ 32.40
8.14

Top Losers

Symbol/Name
LTP
% Chg
ACHR
Archer Aviation Inc...
$ 9.97
-8.11
AMC
AMC Entertainment H...
$ 2.87
-7.42
OKLO
Oklo Inc.
$ 52.29
-6.58
QS
QuantumScape Corpor...
$ 6.29
-6.40
SE
Sea Limited America...
$ 150.49
-5.96